EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line…
Women's Health
-
-
IMPACT ovarian cancer capsules authorised in China
IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for Senaparib capsules to treat ovarian cancer.…
-
EC approves Novartis’ Kisqali to treat early breast cancer
The European Commission (EC) has granted approval to Novartis' Kisqali (ribociclib), plus an aromatase inhibitor to treat early breast cancer…
-
Verastem Oncology submits NDA for ovarian cancer treatment
Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration…
-
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
The US Food and Drug Administration (FDA) has approved Iterum Therapeutics' new drug application (NDA) for ORLYNVAH (sulopenem etzadroxil and…
-
Bayer applies for EU approval of menopause drug elinzanetant
Bayer has submitted a marketing authorisation application to the European Medicines Agency (EMA) for its menopause treatment elinzanetant. Bayer’s pill…
-
How personalised medicine can revolutionise contraception
Across the world, there are 1.9 billion women of reproductive age. According to a 2021 study from the World Health…
-
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV)…
-
Bankrupt Mithra cashes in on remaining assets for $188.2m
A day after filing for bankruptcy, Mithra has sold its share in two of its daughter pharmaceutical companies along with…
-
Cervical cancer elimination in the UK is within sight with HPV vaccine
Cervical cancer is a serious condition but can be prevented with the human papillomavirus (HPV) vaccine. A recent study in…
